Member Login
Username:Password:
or Sign up here
Discover

POLYARTERITIS NODOSA


'Polyarteritis nodosa' (or 'periarteritis nodosa') is a serious blood vessel disease. Small and medium-sized arteries become swollen and damaged when they are attacked by rogue immune cells. Polyarteritis nodosa is also called 'Kussmaul disease' or 'Kussmaul-Meier disease'.[1]

Contents
Causes and risk factors
Incidence
Symptoms
Signs and tests
Treatment and Prognosis
Complications
Prevention
References
External links

Causes and risk factors


Polyarteritis nodosa is a disease of unknown cause that affects arteries, the blood vessels that carry oxygenated blood to organs and tissues. It occurs when certain immune cells attack the affected arteries.

Incidence


The condition affects adults more frequently than children. It damages the tissues supplied by the affected arteries because they don't receive enough oxygen and nourishment without a proper blood supply. Polyarteritis nodosa is more common in people with hepatitis B infection.

Symptoms


In this disease, symptoms result from damage to affected organs, often the skin, heart, kidneys, and nervous system.
Generalised symptoms include fever, fatigue, weakness, loss of appetite, and weight loss. Muscle and joint aches are common. The skin may show rashes, swelling, ulcers, and lumps.
Nerve involvement may cause sensory changes with numbness, pain, burning, and weaknessCentral nervous system involvement may cause strokes or seizures. Kidney involvement can produce varying degrees of renal failure.
Involvement of the arteries of the heart may cause a heart attack, heart failure, and inflammation of the sac around the heart (pericarditis).

Fatigue

Weakness

Fever

Abdominal pain

Decreased appetite

★ Unintentional weight loss

Muscle aches

Joint aches

Signs and tests


There are no specific lab tests for diagnosing polyarteritis nodosa. Diagnosis is generally based upon the physical examination and a few laboratory studies that help to confirm the diagnosis:

CBC (may demonstrate an elevated white blood count)

ESR (often elevated)

★ Perinuclear pattern of antineutrophil cytoplasmic antibodies (p-ANCA) - not associated with "classic" polyarteritis nodosa, but is present in a form of the disease affecting smaller blood vessels, known as microscopic polyangiitis or leukocytoclastic angiitis.

★ Tissue biopsy (reveals inflammation in small arteries, called arteritis)

★ Elevated blood sedimentation rate

★ Elevated c reactive protein
A patient is said to have polyarteritis nodosa if he or she has 3 of the 10 following signs:
1. Weight loss greater than/equal to 4 kg.
2. Livedo reticularis (a mottled purplish skin discoloration over the extremities or torso).
3. Testicular pain or tenderness. (occasionally, a site biopsied for diagnosis).
4. Muscle pain, weakness, or leg tenderness.
5. Nerve disease (either single or multiple).
6. Diastolic blood pressure greater than 90mmHg (high blood pressure).
7. Elevated kidney blood tests (BUN greater than 40 mg/dl or creatinine greater than 1.5 mg/dl).
8. Hepatitis B virus tests positive (for surface antigen or antibody).
9. Arteriogram (angiogram) showing the arteries that are dilated (aneurysms) or constricted by the blood vessel inflammation.
10. Biopsy of tissue showing the arteritis (typically inflamed arteries).[2]

Treatment and Prognosis


Treatment involves medications to suppress the immune system, including prednisone and cyclophosphamide. Therapy results in remissions or cures in 90% of cases. Untreated, the disease is fatal in most cases. The most serious associated conditions generally involve the kidneys and gastrointestinal tract. Without treatment, the outlook is poor.

Complications



Stroke

Kidney failure

Heart attack

★ Intestinal necrosis and perforation

Prevention


This disease cannot be currently prevented, but early treatment can prevent some damage and symptoms.

References


1.
2. Shiel, Jr., William C, http://www.medicinenet.com/polyarteritis_nodosa/article.htm

External links





This article provided by Wikipedia. To edit the contents of this article, click here for original source.